Source:http://linkedlifedata.com/resource/pubmed/id/20175958
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-23
|
pubmed:abstractText |
This study aimed to determine whether CD34 is expressed in glioblastomas and giant cell glioblastomas, as this information may be of value when attempting to differentiate between giant cell glioblastomas and other relevant differential diagnoses such as pleomorphic xanthoastrocytomas with anaplastic features and anaplastic gangliogliomas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0722-5091
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-93
|
pubmed:meshHeading |
pubmed-meshheading:20175958-Antigens, CD34,
pubmed-meshheading:20175958-Astrocytoma,
pubmed-meshheading:20175958-Brain Neoplasms,
pubmed-meshheading:20175958-Diagnosis, Differential,
pubmed-meshheading:20175958-Ganglioglioma,
pubmed-meshheading:20175958-Glioblastoma,
pubmed-meshheading:20175958-Humans,
pubmed-meshheading:20175958-Tumor Markers, Biological
|
pubmed:articleTitle |
CD34 expression in glioblastoma and giant cell glioblastoma.
|
pubmed:affiliation |
Royal Free Hampstead NHS Trust/UCL Medical School, Department of Cellular Pathology, Royal Free Hospital, Pond Street, London, UK. malcolm.galloway@royalfree.nhs.uk
|
pubmed:publicationType |
Journal Article
|